Related Experiment Videos

Biomarkers in acute coronary syndromes and their role in diabetic patients

Christopher Heeschen1

  • 1Experimental Surgery, Department of Surgery, Ludwig-Maximilians-University, Marchioninistrasse 15, 81377 Munich, Germany. christopher.heeschen@med.uni.muenchen.de

Diabetes & Vascular Disease Research
|December 13, 2005
PubMed

Insights

Diabetic patients with acute coronary syndromes need better risk assessment. Utilizing multiple protein biomarkers can improve early diagnosis and guide aggressive treatment, reducing cardiovascular complications.

Area of Science:

  • Cardiology
  • Diabetology
  • Biomarker Research

Background:

  • Diabetic patients with acute coronary syndromes (ACS) face elevated cardiovascular complication risks.
  • Atypical presentations in diabetics can delay diagnosis and treatment initiation.
  • Early risk stratification is crucial for optimizing outcomes in this high-risk group.

Purpose of the Study:

  • To address the challenge of risk stratification in diabetic patients with ACS.
  • To highlight the importance of early diagnosis and treatment for improved outcomes.
  • To explore the utility of novel diagnostic tools beyond traditional methods.

Main Methods:

  • Review of current diagnostic approaches for ACS in diabetic patients.
  • Emphasis on the limitations of electrocardiogram (ECG) for prognostic information in this cohort.
  • Focus on the assessment of circulating protein biomarkers reflecting diverse pathophysiological processes.

Main Results:

  • Standard ECG provides limited prognostic value in diabetic ACS patients.
  • Repeated assessment of circulating protein biomarkers offers a valuable diagnostic approach.
  • Combined biomarkers for necrosis, inflammation, oxidative stress, and neurohumoral activation enhance patient triage.

Conclusions:

  • Multimarker strategies can significantly improve the identification of high-risk diabetic patients with ACS.
  • Early and accurate risk stratification facilitates tailored medical and interventional therapies.
  • Effective management strategies are essential for preventing cardiovascular events in diabetic patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...